MétaCan
Menu
Back to cohort
Record W4324057639 · doi:10.25251/skin.7.supp.139

The impact of tralokinumab on quality of life and school in patients aged 12-17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial

2023· article· en· W4324057639 on OpenAlexaff
Amy S. Paller, Jonathan I. Silverberg, H. Chih ho Hong, Michael J. Cork, L. Puig, Petra Arlert, Azra Kurbasic, Lise Soldbro, Eric L. Simpson

Bibliographic record

VenueSKIN The Journal of Cutaneous Medicine · 2023
Typearticle
Languageen
FieldMedicine
TopicDermatology and Skin Diseases
Canadian institutionsProbity Medical ResearchUniversity of British Columbia
FundersLEO Pharma
KeywordsAtopic dermatitisMedicineQuality of life (healthcare)PediatricsDermatologyNursing

Abstract

fetched live from OpenAlex

Tralokinumab resulted in significantly greater adjusted CDLQI mean change vs placebo, and increased proportions of patients with CDLQI ≥6 • Tralokinumab improved several patient-reported outcomes that encompass psychosocial effects of AD in this vulnerable paediatric age group, as measured by the CDLQI • Tralokinumab had a substantial benefit on the impact of AD on subdomains in the CDLQI related to school/holiday at Week 16 • There was a trend towards treatment benefit with tralokinumab vs placebo across multiple other psychosocial domains • The largest improvements in QoL were seen in the tralokinumab 300 mg group Conclusions References 1.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.005
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.608
Threshold uncertainty score0.616

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.330
Teacher spread0.304 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueSKIN The Journal of Cutaneous MedicineSame topicDermatology and Skin DiseasesFrench-language works237,207